Hi,
moomoo ID:NaN
Log Out
English
Back
Download
Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > COEPW COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) > Detailed Quotes

COEPW COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM)

Watchlist
0.093
-0.003-3.13%
Close  01/31 16:00 ET
High
0.094
Open
0.094
Turnover
1.56K
Low
0.088
Pre Close
0.096
Volume
16.72K
Market Cap
0
P/E(TTM)
0.00
52wk High
0.200
Shares
0
P/E(Static)
0.00
52wk Low
0.010
Float Cap
0
Bid/Ask %
0.00%
Historical High
1.740
Shs Float
0
Volume Ratio
2.26
Historical Low
0.010
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
6.22%
Avg Price
0.093
Lot Size
1
Float Cap
0
Bid/Ask %
0.00%
Historical High
1.740
Shs Float
0
Volume Ratio
2.26
Historical Low
0.010
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
6.22%
Avg Price
0.093
Lot Size
1
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast

News

Comment

News

Announcement

No Data

Company Overview More
Coeptis Therapeutics Holdings, Inc. engages in the development of innovative cell therapy platforms for cancer that have the potential to disrupt conventional treatment paradigms and improve patient outcomes. Its products portfolio consists of cell therapy technology, CD38-GEAR-NK, and an in vitro diagnostic, CD38-Diagnostic, targeting CD38-related cancer. The company is headquartered in Wexford, PA.
CEO： Mr. David Mehalick
Market： NASDAQ
Listing Date： 10/30/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Get Started
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist